HBM Healthcare
Thomas Heimann is currently the Risk Management at HBM Healthcare. Prior to that, they worked as a researcher at SECA - Swiss Private Equity & Corporate Finance Association from January 2009 to December 2011. There, they focused on Venture Capital & Private Equity statistics, trends, policies and implications. Before that, they worked as an assistant to Customer Relationship Manager at Luzerner Kantonalbank from August 2001 to October 2005, where they were responsible for mortgages, loans and real-estate financing for private clients.
Thomas Heimann has vast experience in the financial industry, having worked in various sectors including private equity, venture capital, and wealth management. Thomas is an expert in risk management and has helped numerous companies navigate through difficult financial times. Thomas is a trusted advisor and their advice is highly sought after by both individuals and businesses alike.
Thomas Heimann has a MSc in Banking and Finance from Lucerne University of Applied Sciences and Arts / Zurich University of Applied Sciences, and a BSc in Finance and Banking from Lucerne University of Applied Sciences and Arts.
They are on a team with Miranda Guo - Investment Advisor, Hong Kong, Nina Good - Compliance, and Alexander Asam - Investment Advisor. Thomas Heimann reports to Andreas Wicki, CEO.
This person is not in any offices
HBM Healthcare
HBM Healthcare Investments invests in the healthcare sector. The Company holds and manages an international portfolio of promising companies in the human medicine, biotechnology, medical technology and diagnostics sectors and related areas. Many of these companies have their lead products already available on the market or at an advanced stage of development.